J.W. Cole Advisors Inc. Reduces Stock Holdings in Axon Enterprise, Inc $AXON

J.W. Cole Advisors Inc. decreased its position in Axon Enterprise, Inc (NASDAQ:AXON) by 31.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,061 shares of the biotechnology company’s stock after selling 3,714 shares during the period. J.W. Cole Advisors Inc.’s holdings in Axon Enterprise were worth $4,566,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in AXON. Creative Financial Designs Inc. ADV purchased a new stake in shares of Axon Enterprise during the fourth quarter worth $28,000. New Millennium Group LLC purchased a new stake in shares of Axon Enterprise during the third quarter worth $29,000. Sound Income Strategies LLC lifted its position in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after acquiring an additional 44 shares in the last quarter. Camelot Portfolios LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth $30,000. Finally, Lodestone Wealth Management LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth $35,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on AXON shares. Piper Sandler dropped their target price on Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating on the stock in a research report on Thursday, May 7th. Craig Hallum restated a “buy” rating and set a $820.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 25th. Needham & Company LLC dropped their target price on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a research report on Friday, February 20th. Citigroup restated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, February 25th. Finally, The Goldman Sachs Group set a $535.00 target price on Axon Enterprise in a research report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $712.75.

Axon Enterprise Trading Down 5.3%

Axon Enterprise stock opened at $486.12 on Friday. The stock has a market cap of $39.18 billion, a P/E ratio of 195.23, a PEG ratio of 9.33 and a beta of 1.45. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The firm’s fifty day moving average price is $408.04 and its 200-day moving average price is $491.92. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.01. The firm had revenue of $807.35 million for the quarter, compared to analysts’ expectations of $778.91 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The business’s quarterly revenue was up 33.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.47 earnings per share. Equities research analysts forecast that Axon Enterprise, Inc will post 1.82 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Isaiah Fields sold 2,000 shares of the company’s stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $400.00, for a total value of $800,000.00. Following the transaction, the insider owned 52,813 shares of the company’s stock, valued at approximately $21,125,200. This represents a 3.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 564 shares of the company’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $478.97, for a total transaction of $270,139.08. Following the completion of the transaction, the director directly owned 3,632 shares in the company, valued at approximately $1,739,619.04. The trade was a 13.44% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 3,548 shares of company stock worth $1,542,775. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.